Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 310.5469
- Book/Share 57.6123
- PB 1.3493
- Debt/Equity 1.121
- CurrentRatio 0.8319
- ROIC 0.0043
- MktCap 98431602200.0
- FreeCF/Share 4.959
- PFCF 15.6414
- PE 209.8044
- Debt/Assets 0.3202
- DivYield 0.0343
- ROE 0.0062
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies
Published: November 06, 2025 by: Business Wire
Sentiment: Neutral
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the United States, replacing OneTouch® branded blood glucose monitors and test strips. The TRUE METRIX® portfolio delivers scientifically backed performance built on decades of research and technological innovation. The TRUE METRIX meters and test strips feature TRIP.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Published: October 31, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America.
Read More
My Top 10 High-Yield Picks For November 2025: One Yields 9%+
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Positive
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, attractive yields, reasonable payout ratios, and a proven record or potential for dividend growth. CVX and ARCC receive positive Wall Street ratings, while VZ and MO offer high yields and strong free cash flow, supporting portfolio income stability.
Read More
CVS Posts Loss on Write-Down, Boosts Guidance
Published: October 29, 2025 by: WSJ
Sentiment: Neutral
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
Read More
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.
Read More
CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings
Published: October 29, 2025 by: Market Watch
Sentiment: Negative
CVS Health's stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report.
Read More
CVS Posts Loss on Write-Down, Boosts Guidance
Published: October 29, 2025 by: WSJ
Sentiment: Neutral
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
Read More
CVS Reports Big Loss On Devalued Oak Street Clinics But Aetna Costs Are Stable
Published: October 29, 2025 by: Forbes
Sentiment: Negative
CVS Health Wednesday reported a $4 billion third-quarter loss related to the reduced value of its Oak Street Health primary care facilities, but the company is getting a handle on health costs that have hit its Aetna health insurance business.
Read More
CVS raises full-year forecast, takes $5.7 billion impairment charge on health clinics
Published: October 29, 2025 by: Reuters
Sentiment: Neutral
CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics.
Read More
CVS beats estimates, hikes guidance as insurance business improves
Published: October 29, 2025 by: CNBC
Sentiment: Positive
CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap David Joyner's first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.
Read More
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
Published: October 29, 2025 by: PRNewsWire
Sentiment: Neutral
Financial Highlights Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior year Third quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit Third quarter Adjusted EPS of $1.60 Generated year-to-date cash flow from operations of $7.2 billion Operational Highlights Aetna® receives industry-leading Medicare Advantage Star Ratings results Launch of annual vaccination campaign at CVS Pharmacy® and MinuteClinic® locations nationwide Caremark® closes out another strong selling season with contract wins totaling nearly $6.0 billion and retention in the high …
Read More
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
Read More
CVS Health: Slow And Steady Wins The Healthcare Race
Published: October 27, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and continued double-digit growth in health services and pharmacy segments. CVS stock trades at a significant valuation discount to sector and market averages, despite steady top-line growth and a 3.25% dividend yield.
Read More
CVS To Close 16 Oak Street Health Centers Amid Industry Cost Issues
Published: October 24, 2025 by: Forbes
Sentiment: Negative
CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates across the U.S.
Read More
CVS Stock: $31 Bil Shareholder Returns
Published: October 24, 2025 by: Forbes
Sentiment: Positive
Over the past ten years, CVS Health stock (NYSE: CVS) has returned $31 billion to shareholders in the form of cash through dividends and buybacks. This shareholder-focused strategy has delivered exceptional results in 2025, with the stock posting a remarkable 81% year-to-date return, representing one of the most dramatic healthcare sector turnarounds after suffering a 42% decline in 2024 and demonstrating the company's successful navigation through post-pandemic challenges.
Read More
Countdown to CVS Health (CVS) Q3 Earnings: Wall Street Forecasts for Key Metrics
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
CVS Expands Its Nationwide Care Network With Rite Aid Acquisition
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.
Read More
Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.
Read More
Here's Why CVS Health (CVS) is a Strong Momentum Stock
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Are Medical Stocks Lagging CVS Health (CVS) This Year?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how CVS Health (CVS) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
5 Low Price-to-Book Stocks Worth Considering in October
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
STNE, CVS, KT, PAGS and ARW are five low price-to-book stocks that combine value appeal with solid growth potential.
Read More
CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers
Published: October 15, 2025 by: Forbes
Sentiment: Positive
CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday.
Read More
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Jim Cramer's top 10 things to watch in the stock market Tuesday
Published: October 14, 2025 by: CNBC
Sentiment: Negative
Stock futures fell Tuesday as trade tensions between the U.S. and China intensified.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000